tiprankstipranks
CuraScientific (CSTF)
OTHER OTC:CSTF
US Market

CuraScientific (CSTF) Ratios

12 Followers

CuraScientific Ratios

CSTF's free cash flow for Q3 2023 was $-2.46. For the 2023 fiscal year, CSTF's free cash flow was decreased by $ and operating cash flow was $-24.15. See a summary of the company’s cash flow.
Ratios
TTM
Dec 22Dec 21Dec 20Dec 19
Liquidity Ratios
Current Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Quick Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Cash Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Solvency Ratio
-0.07 -0.07 -0.07 -0.02 <0.01
Operating Cash Flow Ratio
>-0.01 >-0.01 >-0.01 >-0.01 <0.01
Short-Term Operating Cash Flow Coverage
-0.10 -0.10 -0.52 -0.99 0.01
Net Current Asset Value
$ -71.02M$ -71.02M$ -71.50M$ -199.42M$ -394.52K
Leverage Ratios
Debt-to-Assets Ratio
1.70 1.70 0.47 0.16 1.02
Debt-to-Equity Ratio
-0.04 -0.04 -0.02 >-0.01 -41.86
Debt-to-Capital Ratio
-0.04 -0.04 -0.02 >-0.01 1.02
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 1.02
Financial Leverage Ratio
-0.02 -0.02 -0.03 -0.01 -40.86
Debt Service Coverage Ratio
-0.89 -0.89 -1.85 -5.09 0.10
Interest Coverage Ratio
-1.95 -1.95 -4.13 -6.87 0.21
Debt to Market Cap
6.99 0.06 0.02 <0.01 0.07
Interest Debt Per Share
0.82 0.82 7.29 13.69 672.04
Net Debt to EBITDA
-0.77 -0.77 -0.25 -0.11 28.49
Profitability Margins
Gross Profit Margin
-3298.12%-3298.12%64.12%69.35%67.45%
EBIT Margin
-11759.33%-11759.33%-5463.62%-7472.98%3.57%
EBITDA Margin
-9969.64%-9969.64%-4754.88%-6831.33%17.07%
Operating Profit Margin
-6910.85%-6910.85%-5537.09%-4210.35%3.57%
Pretax Profit Margin
-15299.16%-15299.16%-6805.12%-8085.52%-13.09%
Net Profit Margin
-15299.16%-15299.16%-6805.12%-8085.52%-13.09%
Continuous Operations Profit Margin
-15299.16%-15299.16%-6805.12%-8085.52%-13.09%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
221.38%221.38%122.90%192.04%-366.46%
Return on Assets (ROA)
-339.49%-339.49%-262.01%-177.96%-2.74%
Return on Equity (ROE)
7.59%7.58%8.46%2.47%111.97%
Return on Capital Employed (ROCE)
3.44%3.44%6.88%1.29%-1.57%
Return on Invested Capital (ROIC)
3.57%3.57%6.99%1.29%-4.50%
Return on Tangible Assets
-4155.16%-4155.16%-2725.58%-4495.01%-2.74%
Earnings Yield
-1114826.08%-11.15%-9.20%-1.22%-0.14%
Efficiency Ratios
Receivables Turnover
0.00 0.00 5.17 0.00 0.00
Payables Turnover
3.54 3.54 0.27 0.14 0.00
Inventory Turnover
0.00 0.00 3.68 2.68 0.00
Fixed Asset Turnover
0.40 0.40 0.98 0.64 0.78
Asset Turnover
0.02 0.02 0.04 0.02 0.21
Working Capital Turnover Ratio
>-0.01 >-0.01 >-0.01 >-0.01 -0.29
Cash Conversion Cycle
-103.09 -103.09 -1.17K -2.57K 0.00
Days of Sales Outstanding
0.00 0.00 70.64 0.00 0.00
Days of Inventory Outstanding
0.00 0.00 99.11 136.35 0.00
Days of Payables Outstanding
103.09 103.09 1.34K 2.70K 0.00
Operating Cycle
0.00 0.00 169.75 136.35 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
-0.05 -0.05 -1.82 -7.34 2.12
Free Cash Flow Per Share
-0.06 -0.06 -1.84 -7.34 2.12
CapEx Per Share
<0.01 <0.01 0.02 0.00 0.00
Free Cash Flow to Operating Cash Flow
1.06 1.06 1.01 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
-17.01 -17.01 -98.64 0.00 0.33
Capital Expenditure Coverage Ratio
-17.01 -17.01 -98.64 0.00 0.00
Operating Cash Flow Coverage Ratio
-0.10 -0.10 -0.52 -0.99 <0.01
Operating Cash Flow to Sales Ratio
-7.37 -7.37 -6.42 -7.20 0.02
Free Cash Flow Yield
-71.19%-0.57%-0.88%-0.11%0.02%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
>-0.01 -8.97 -10.87 -81.85 -717.24
Price-to-Sales (P/S) Ratio
10.96 1.37K 739.82 6.62K 93.90
Price-to-Book (P/B) Ratio
>-0.01 -0.68 -0.92 -2.02 -803.09
Price-to-Free Cash Flow (P/FCF) Ratio
-1.40 -175.92 -114.08 -918.57 5.89K
Price-to-Operating Cash Flow Ratio
>-0.01 -186.26 -115.24 -918.57 5.89K
Price-to-Earnings Growth (PEG) Ratio
>-0.01 0.10 0.14 -0.22 -0.58
Price-to-Fair Value
>-0.01 -0.68 -0.92 -2.02 -803.09
Enterprise Value Multiple
-0.88 -14.53 -15.81 -96.98 578.51
Enterprise Value
3.01M 49.89M 64.85M 398.53M 8.04M
EV to EBITDA
-0.88 -14.53 -15.81 -96.98 578.51
EV to Sales
87.55 1.45K 751.83 6.62K 98.76
EV to Free Cash Flow
-11.22 -185.73 -115.93 -919.57 6.20K
EV to Operating Cash Flow
-11.88 -196.65 -117.11 -919.57 6.20K
Tangible Book Value Per Share
-15.01 -15.01 -234.99 -3.38K -15.53
Shareholders’ Equity Per Share
-14.71 -14.71 -228.33 -3.33K -15.53
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.00 0.00 0.00
Revenue Per Share
<0.01 <0.01 0.28 1.02 132.80
Net Income Per Share
-1.11 -1.11 -19.32 -82.40 -17.39
Tax Burden
1.00 1.00 1.00 1.00 1.00
Interest Burden
1.30 1.30 1.25 1.08 -3.67
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
51.85 51.85 48.92 36.38 0.90
Stock-Based Compensation to Revenue
13.79 13.79 38.29 26.60 0.00
Income Quality
0.05 0.05 0.09 0.09 -0.12
Currency in USD